These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16300636)

  • 1. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.
    Waltereit R; Welzl H; Dichgans J; Lipp HP; Schmidt WJ; Weller M
    J Neurochem; 2006 Jan; 96(2):407-13. PubMed ID: 16300636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired synaptic plasticity in a rat model of tuberous sclerosis.
    von der Brelie C; Waltereit R; Zhang L; Beck H; Kirschstein T
    Eur J Neurosci; 2006 Feb; 23(3):686-92. PubMed ID: 16487150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.
    Chu-Shore CJ; Major P; Montenegro M; Thiele E
    Neurology; 2009 Mar; 72(13):1165-9. PubMed ID: 19332694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.
    Jansen FE; Braams O; Vincken KL; Algra A; Anbeek P; Jennekens-Schinkel A; Halley D; Zonnenberg BA; van den Ouweland A; van Huffelen AC; van Nieuwenhuizen O; Nellist M
    Neurology; 2008 Mar; 70(12):908-15. PubMed ID: 18032745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
    Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
    Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis complex and epilepsy: recent developments and future challenges.
    Holmes GL; Stafstrom CE;
    Epilepsia; 2007 Apr; 48(4):617-30. PubMed ID: 17386056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
    Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
    Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation.
    Rok P; Kasprzyk-Obara J; Domańska-Pakieła D; Jóźwiak S
    Med Sci Monit; 2005 May; 11(5):CR230-234. PubMed ID: 15874888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
    Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
    Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures.
    Goorden SM; van Woerden GM; van der Weerd L; Cheadle JP; Elgersma Y
    Ann Neurol; 2007 Dec; 62(6):648-55. PubMed ID: 18067135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
    Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
    Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.
    Choi JE; Chae JH; Hwang YS; Kim KJ
    Brain Dev; 2006 Aug; 28(7):440-6. PubMed ID: 16554133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.
    Hung CC; Su YN; Chien SC; Liou HH; Chen CC; Chen PC; Hsieh CJ; Chen CP; Lee WT; Lin WL; Lee CN
    BMC Med Genet; 2006 Sep; 7():72. PubMed ID: 16981987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
    Tavazoie SF; Alvarez VA; Ridenour DA; Kwiatkowski DJ; Sabatini BL
    Nat Neurosci; 2005 Dec; 8(12):1727-34. PubMed ID: 16286931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds.
    Wentink M; Nellist M; Hoogeveen-Westerveld M; Zonnenberg B; van der Kolk D; van Essen T; Park SM; Woods G; Cohn-Hokke P; Brussel W; Smeets E; Brooks A; Halley D; van den Ouweland A; Maat-Kievit A
    Clin Genet; 2012 May; 81(5):453-61. PubMed ID: 21332470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
    Rosner M; Freilinger A; Hengstschläger M
    Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.